DK

Dilip Kamalakar Pimple

Active Director Director DIN 02433809
DIN 02433809 First appointment Feb 1998 Primary industry Business Outsourcing
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Feb 1998
Shareholding value •••• Premium profile

About Dilip Kamalakar Pimple

Data last updated:

Dilip Kamalakar Pimple is a Director at Uday Chemical Engineers And Projects Limited (since 2018), Director at Vetpharma Limited (since 1998) and Director at Purecare Pharma Limited (since 2016). The companies operate in Business Outsourcing, Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹2.34 Cr; the largest is Uday Chemical Engineers And Projects Limited at ₹1.38 Cr (FY 2015). Earlier, Dilip Kamalakar Pimple was a Whole-Time Director at Nutraplus India Limited (2006–2020) and Additional Director at Uce Projects Private Limited (2017–2021) and 1 more.

DIN 02433809
Primary Designation Director
Industry Business Outsourcing
First Appointment 23 Feb 1998
Oldest Company Age 31 yrs
Largest company Uday Chemical Engineers And Projects Limited · ₹1.38 Cr (FY 2015)
Combined revenue ₹2.34 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Aug 20181995₹1.38 Cr (FY 2015)Active
Vetpharma Limited U24239MH1995PLC088169
Director23 Feb 19981995₹96.5 Lakh (FY 2022)Active
Purecare Pharma Limited U24297MH2016PLC273844
Director03 Mar 20162016Dormant Under Section 455

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nutraplus India Limited L24230MH1990PLC055347
Whole-Time Director28 Jul 20061990Active
Uce Projects Private Limited U74999MH2010PTC199462
Additional Director28 Feb 20172010Active
Astere Greene Energy Private Limited U35201MH2015PTC267396
Director11 Aug 20152015Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Dilip Kamalakar Pimple

Directorship timeline

Open interactive timeline →
Vetpharma Limited
Purecare Pharma Limited
Uday Chemical Engineers And Projects Limited
Nutraplus India Limited
Premium access

Shareholding and investment profile for Dilip Kamalakar Pimple

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dilip Kamalakar Pimple

Dilip Kamalakar Pimple currently holds 3 directorships: Uday Chemical Engineers And Projects Limited (Director, since 17 Aug 2018, revenue ₹1.38 Cr (FY 2015)); Vetpharma Limited (Director, since 23 Feb 1998, revenue ₹96.5 Lakh (FY 2022)); Purecare Pharma Limited (Director, since 03 Mar 2016).

Dilip Kamalakar Pimple was first appointed on 23 Feb 1998 as Director at Vetpharma Limited. The most recent appointment on record is 17 Aug 2018 at Uday Chemical Engineers And Projects Limited.

The 2 current companies of Dilip Kamalakar Pimple that report revenue have a combined latest revenue of ₹2.34 Cr: Uday Chemical Engineers And Projects Limited ₹1.38 Cr (FY 2015); Vetpharma Limited ₹96.5 Lakh (FY 2022).

Dilip Kamalakar Pimple held 3 earlier board appointments: Nutraplus India Limited (Whole-Time Director, 28 Jul 2006 to 06 Mar 2020); Uce Projects Private Limited (Additional Director, 28 Feb 2017 to 06 Jul 2021); Astere Greene Energy Private Limited (Director, 11 Aug 2015 to 06 Oct 2020).

The current boards of Dilip Kamalakar Pimple's companies include Mukesh Dhirubhai Naik (Uday Chemical Engineers And Projects Limited), Uday Desai (Uday Chemical Engineers And Projects Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available